Novartis Ag NVS
NYSE NVS
$140.35 -0.58 (-0.41%)
At close: Sep 18, 2026 · 4:00 PM EDT

Novartis Ag (NVS) Intangibles (2009 - 2026)

Novartis Ag's (NVS) quarterly Intangibles came in at $42.1 billion in Q2 2026, up 43.89% year-over-year from $29.2 billion in Q2 2025, and up 4.64% quarter-over-quarter from $40.2 billion in Q1 2026.

Analysis

Novartis Ag (NVS) Intangibles (2009 - 2026) Analysis & Trends

Novartis Ag has disclosed Intangibles across 18 years of filings, most recently posting $42.1 billion for Q2 2026.

  • In Q2 2026, Intangibles rose 43.89% year-over-year to $42.1 billion; the TTM figure through Jun 2026 stood at $42.1 billion (up 43.89% YoY), while the FY2025 annual figure was $29.4 billion, up 9.27% from the prior year.
  • Intangibles came in at $42.1 billion for Q2 2026 at Novartis Ag, up from $40.2 billion in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $42.1 billion in Q2 2026 to a low of $1.6 billion in Q1 2023.
  • Average Intangibles over 5 years is $28.9 billion, with a median of $28.5 billion recorded in 2023.
  • Year-over-year, Intangibles plunged 95.54% in 2023 and jumped 1591.69% in 2024.
  • Over 5 years, Intangibles stood at $31.6 billion in 2022, then decreased by 15.06% to $26.9 billion in 2023, then rose by 0.13% to $26.9 billion in 2024, then advanced by 9.27% to $29.4 billion in 2025, then soared by 43.06% to $42.1 billion in 2026.
  • Per Business Quant data, the three most recent Intangibles figures were $42.1 billion in Q2 2026, $40.2 billion in Q1 2026, and $29.4 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 48.23 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 49.14 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 24.98 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 42.07 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 47.05 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 17.39 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 30.64 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn - 63.28 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 60.96 Mn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn 103.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42.07 Bn
Mar 31, 2026 40.21 Bn
Dec 31, 2025 29.41 Bn
Sep 30, 2025 29.04 Bn
Jun 30, 2025 29.24 Bn
Mar 31, 2025 27.48 Bn
Dec 31, 2024 26.92 Bn
Sep 30, 2024 27.90 Bn
Jun 30, 2024 27.78 Bn
Mar 31, 2024 26.27 Bn
Dec 31, 2023 26.88 Bn
Sep 30, 2023 26.42 Bn
Jun 30, 2023 28.00 Bn
Mar 31, 2023 1.55 Bn
Dec 31, 2022 31.64 Bn
Sep 30, 2022 31.89 Bn
Jun 30, 2022 33.37 Bn
Mar 31, 2022 34.85 Bn
Dec 31, 2021 34.18 Bn
Sep 30, 2021 33.95 Bn